Study Phase 3

Efficacy and pharmacokinetic/pharmacodynamic profile of ibuprofen chewable tablets versus ibuprofen suspension in febrile children. CSR 167S. Protocol 91-113, Unpublished Report 293A and Unpublished Report 1475.

Trial Information

Generic NameIbuprofenProduct NamePediaProfenTherapeutic AreaMusculo-Skeletal SystemProduct ClassAnti-Inflammatory and Antirheumatic ProductsPharmacological SubgroupAnti-Inflammatory and Antirheumatic Products, Non-SteroidsChemical SubgroupPropionic Acid DerivativesCondition StudiedFever
Sponsor Protocol Number91-113Enrollment85Data PartnerKenvue Brands LLC% Female48.2%Mean/Median Age (Years)N/A% WhiteN/A

Supporting Documentation

  • Collected Datasets Available
  • Protocol with Amendments Available
  • Clinical Study Report Available
Additional Information

Only a limited collected dataset can be made available.

Approved Data Requests Associated with this Trial

Disclaimer

Clinical study data provided through this site do not replace the official labeling of a given drug product, which presents benefits and risks of the product for approved use(s). Before prescribing any product, health care professionals should consult the current prescribing information approved in their country. Patients seeking information may consult with their health care professional about the product, for which health authority approved written patient information may be available.